Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-02-22
2000-08-15
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514826, A61K 3133
Patent
active
061037125
ABSTRACT:
A method for treating asthma and disease conditions associated therewith is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((2"-ethoxy)-3'"-(O)-4'"-(N,N-dimethylamino)-butane)-bi s-(3,3'-indoly1)]-1 (H)-pyrrole-2,5-dione and its pharmaceutically acceptable salts.
REFERENCES:
patent: 5057614 (1991-10-01), Davis et al.
patent: 5481003 (1996-01-01), Gillig et al.
patent: 5491242 (1996-02-01), Gillig et al.
patent: 5545636 (1996-08-01), Heath, Jr. et al.
patent: 5552396 (1996-09-01), Heath, Jr. et al.
patent: 5559228 (1996-09-01), Gillig et al.
patent: 5621098 (1997-04-01), Heath, Jr. et al.
patent: 5710145 (1998-01-01), Engel et al.
patent: 5780461 (1998-07-01), Heath, Jr. et al.
Wilkinson et al. "Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C" Biochem J. (1993) 294 pp. 335-337.
Darkes Paul R.
Eli Lilly and Company
Jordan Kimberly
LandOfFree
Therapeutic treatment for asthma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic treatment for asthma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment for asthma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2006987